ABSTRACT
INTRODUCTION
Sepsis is a complex syndrome that results from the host response to infection and leads to tissue injury and inflammation.
During systemic bacterial sepsis, the involvement of the liver in the inflammatory process seems to play a main role in the cascading events that eventually involve most of the body organs (1) . Gram negative sepsis induced largely by bacterial lipopolysaccharides (LPS) stimulates hepatic production of acute phase proteins, such as Creactive protein, serum amyloid A (SAA), CD14, and LPS binding protein (LBP), which may actually function to restrict LPS action (2) . Within the extremely complex cascade of the pathophysiological events representing the systemic inflammatory response, hepatocellular apoptosis has been identified as a crucial step in the induction of the acute liver failure that frequently complicates systemic bacterial sepsis (3) . Apoptosis leads to leukocyte migration and attack on parenchymal cells (4) thereby establishing a vicious circle with aggravation of leukocytic inflammation and final cell death. It has been shown that preventing apoptosis in hepatocytes by caspase inhibition suppresses leukocyte transmigration and leukocytedependent liver cell necrosis. The differential effect of female sex hormones on systemic inflammatory response in various organs has been investigated in several tissues. Some studies have suggested that estrogen therapy in postmenopausal women can increase hepatic C reactive protein production.
(7) and others have shown that it can also increase the production of IL 6 suggesting a pro-inflammatory role for the hormone.
(8)
However, Wakatsuki et al.
(9) have suggested that the dose of estrogen supplementation seems to influence its effect on inflammatory markers where a high dose increases the serum levels of C reactive protein, IL 6 and serum amyloid A while a low dose did not increase such markers. On the other hand, Sunday et al. also suggested that estrogen in experimental animals reduced inflammatory markers in cerebral blood vessels (10) . The effect of progesterone on cardiovascular and cerebrovascular function has produced a lot of controversy. Some studies have shown beneficial effects of progesterone, whereas others show little or no effect. For example, progesterone has been shown to produce a positive effect on exerciseinduced myocardial ischemia and on the outcome of experimental stroke (11) . However, Sunday et al.
(10) suggested that progesterone analogues increased the levels of inflammatory markers and exacerbated cerebrovascular inflammatory response.
In the genital tract, Kautschic et al . (12) reported that the hormonal environment at the time of pathogen exposure can have a distinct effect on the outcome of a microbial infection. They studied the susceptibility and degree of inflammation encountered in the genital tracts of ovariectomized rats subjected to chlamydial infection. They concluded that estradiol supplementation in ovariectomized animals decreases susceptibility; it also seems to have a strong antiinflammatory response. Progesterone, on the other hand, seems to enhance both susceptibility and inflammatory responses. With the combination of hormones used in these experiments, estradiol effect on inflammation predominates whereas progesterone affects primarily susceptibility.
The aim of this limited study was to evaluate the effect of ovariectomy and the differential effect of estrogen and progesterone supplementation in ovariectomized animals on the inflammatory and apoptotic response in a rat model of acute septic systemic inflammation. We measured markers of systemic inflammation in the serum and evaluated the level of expression and activity of several proinflammatory and apoptotic enzymes in liver tissues of different groups of studied animals.
MATERIAL & METHODS

Experimental animals
This study involved 48 female albino rats weighing between 200-240 g. Their age ranged between 9-10 weeks at the start of the protocol. The animals were randomly divided into six groups each consisting of 8 rats. Animals were fed a standard diet and housed in the animal house of Kasr Al-Aini Faculty of Medicine with a 12:12-h light/dark cycle. The protocol for the study has been approved by the Faculty Ethics Committee.
In order to evaluate the differential effect of estradiol and progesterone on the systemic inflammatory response, all groups except groups I and II were subjected to bilateral ventral ovariectomy which was followed by either no hormonal supplementation, a single form of hormonal supplementation or a combined form of hormonal supplementation for three weeks. Groups I and II were subjected to a sham ovariectomy at the beginning of the protocol.
At the end of the three weeks period, induction of systemic inflammation by ileoceacal ligation and puncture then followed in all groups except group I. 24 hours after the ileoceacal puncture was induced, blood samples were obtained under anaesthesia and the animals were then sacrificed and their liver tissue extracted for further analysis of tissue markers of inflammation and apoptosis. 
Analysis of iNOS expression in liver homogenates
The rats were sacrificed and the liver excised and about 30 mg of fresh tissue was homogenized in 175uL RNA lysis solution which contains guanidinum thiocynate and BB mercaptoethanol and was centrifuged at 10.000 rpm for 10 minutes at 4°C. Then, the supernatants were kept frozen at -80°C till examination for expression of iNOS by RT-PCR. Total RNA was extracted from liver tissue using SV total RNA isolation system (Promega Madison, USA) according to the method described by Chomzanschi and Sacchi (17) . About 5 ug of RNA was reverse transcribed and amplified using one step RT-PCR kit supplied by Ziagen (Valencia, California, USA). Two primer sets were used, one for the target gene (iNOS) and the other for the housekeeping gene (B-activin). Inducible NOS forward primer 5-CAG GAC CAC ACC CCC TCG GA-3 and reverse primer 5 -AGC CAC ATC CCG AGC CAT GC-3 were used and the PCR product was 537bp. Forward B activin primer (5 TGTT GTCCC TGTATGCCTCT3) and reverse primer 5 TAA T GT CAC GCA CGA TTT CC3 ) were used and the PCR product was 206bp.
The PCR mixture contained 10ul of 10x PCR buffer, 2ul of 25mM MgCl2, 2ul of 10mM dNTPS mix, 2.5 units of taq DNA polymerase and 100pmol of each forward and reverse priers in a total volume of 100uL. The mixture was processed for 40 cycles in a thermal cycler. The PCR cycling conditions were 94°C for 1 min for denaturation followed by 62°C for 1 min and 72°C for 1 min. Following the final cycle, final extension at 72°C for 10 min was performed. Gel electrophoresis: 10 μl of PCR product was analyzed on 2% agarose gel with ethidium bromide staining and the product was visualized on ultraviolet transilluminator, then gel documentation was performed. PCR products were semi-quantified by using a gel documentation system (Bio Doc Analyze) supplied by Biometra. Caspase 3 activity and COXII.
About 0.5g of liver tissue was dissected and perfused with PBS (PBS).
30 mg of fresh liver tissue was homogenized in extraction buffer and centrifuged and 10.000 rpm for 15 min, at 4°C. The supernatant was stored at -80°C for one month for COXII (assay design,Victoria, Canada) and Caspase3 activity immunoassay (Quantikin R and D systems, Minneapolis, USA) following the manufacturer's instructions.
Methods Induction of ovariectomy in Female rats:
Ovariectomy was performed in groups III, IV, V, and VI at the start of the protocol while in group I and II, a sham operation was performed.
Animals in groups III, IV, V and VI were anaesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (2.5 mg/kg). The animals were then bilaterally ovariectomized (OVX) through a midventral incision three weeks before induction of systemic inflammation.
In groups I and II, the skin and muscle incisions were performed under anaesthesia but no ovariectomy was performed and the wound was sutured under aseptic conditions as in the other groups.
Hormonal replacement:
Ovariectomized animals (OVX) received hormonal replacement for three weeks before induction of systemic inflammation. The treatment was in the form of daily subcutaneous injections (SC) of either estradiol benzoate or progestererone or both forms of treatment according to the group the animals belonged to. Estradiol benzoate was given in the dose of 4 µg/100 g (BW) in 200 µl oil while progesterone was injected in the dose of 5 mg /kg BW in oil. Estrogen and progesterone were purchased as ampoules of estradiol benzoate and progesterone produced by Misr company for pharmaceuticals.
Induction of systemic inflammation
Animals were anesthetized with an intra -peritoneal injection of ketamine (100 mg/kg) and xylazine (2.5 mg/kg) then subjected to a midline ventral laparotomy with exposure and isolation of the caecum. The caecum was tied off 1 cm from the end and punctured with a single hole by using a 21-gauge needle. Animals were resuscitated with 2 ml of sterile saline administered subcutaneously after closure of the wound. 
Statistical analysis
Data are expressed as mean ±SD. Groups were compared using Student's t-test or by ANOVA with Post hoc for analysis for statistical significance between groups. A p-value less than 0.05 was considered significant.
RESULTS
Estrogen and Progesterone
Ovariectomy was associated with a significant reduction in the levels of estrogen in animals subjected to systemic inflammation (group III) when compared to control (group I) (8±1.2 versus 50±5.3 pg/ml) (P≤0.005) and also to animals with systemic inflammation without prior ovariectomy (group II =42±3.5 pg/ml). (P≤0.05).
However, progesterone levels in group III (ovx+SI=14±1.6ng/ml) were actually significantly higher from levels obtained in group II (9±0.8 ng/ml) and even group I (control=11±0.9ng/ml). ( P≤0.05) Daily supplementation with estrogen after ovariectomy in group IV resulted in a significant increase in both estrogen (63±4.1pg/ml) and progesterone levels (19±4.2 ng/ml) at time of measurement when compared to corresponding levels in groups (I, II and III). (P≤0.05).
Daily supplementation with progesterone (5mg/kg BW) after ovariectomy in group V resulted in a significant increase in progesterone levels in group V (36±1.8 ng/ml) when compared to corresponding levels in groups (I=11±0.9ng/ml, II=9±0.8 ng/ml, III=14±1.6 ng/ml, and IV=19±4.2 ng/ml). (P≤0.005).
Estrogen levels in group V (7±1.9 pg/ml) were significantly lower in this group than corresponding levels in groups I=50±5.3 pg/ml, II=42±3.5 pg/ml and IV=63±4.1pg/ml, P ≤0.005). Daily supplementation with both estrogen (dose 4ug/100g BW ) and progesterone (5mg/Kg BW) for three weeks in ovariectomized animals followed by induction of systemic inflammation (group VI) resulted in estrogen levels (43 ± 2.8pg/ml) similar to levels encountered in group II (SI only) (42±3.5pg/ml, P ≥0.05) however, progesterone levels (38 ± 0.9ng/ml) were significantly higher than those encountered in group II 
Lane M : PCR marker with 100 bp ladder Lane 1: PCR products of iNOS gene in control group Lane 2: PCR products of iNOS gene in 0vx+SI group Lane 3: PCR products of iNOS gene in SI group Lane 4: PCR products of iNOS gene in Ovx+SI+E group Lane 5: PCR products of iNOS gene in Ovx+SI+P group Lane 6: PCR products of iNOS gene in Ovx+SI+E+P group
DISCUSSION
Our results showed that induction of systemic inflammation in intact non ovariectomized animals led to a significant increase in the levels of inflammatory markers, TNFα, C reactive protein as well as liver enzymes in the serum of animals. This was associated with increased expression of iNOS, and activity of COX II and Caspase 3 enzymes in liver tissue samples and also a significant reduction of serum estrogen and progesterone levels when compared to control levels.
Patel Our observation that systemic inflammation in group II was associated with a reduction of sex hormones can be partly interpreted by a role played by the observed significant increase in iNOS expression. It has been suggested that iNOS can be expressed in moderate to high levels in brain tissue in infectious or inflammatory conditions. High NO levels may also result in feedback inhibition of NOS activity and/or expression (28) and also elicit a direct inhibition of GnRH synthesis. The latter may occur through the interaction with an element in the GnRH gene promoter that is repressed by the NO-mediated cGMP signal transduction pathway (29) . It has also been suggested that inflammatory markers such as IL1 are involved in the immune system and have a role in ovarian inflammation as well s exhibiting a direct inhibitory effect on the ovarian steroidogenesis and folliculogenesis (30) , a finding which may further reduce the production of the measured hormones in group II animals when compared to the control group.
A rather surprising finding was that in group III systemic inflammation in ovarietomized animals, there was actually an increase in serum progesterone to levels higher than control group or group II (animals with systemic inflammation). Our results can be interpreted by the findings of Flores et al. 2008 (31) who suggested that the adrenals are the main source of progesterone in rats while the ovaries are the main source of estradiol and testosterone during the cycle. They also suggested that a ventral approach to ovariectomy as the one we used in our experiments results in higher levels of observed progesterone levels when compared to a dorsal approach due to stimulation of neural pathways arising from the dorsal and ventral peritoneum. .
There is strong evidence that stress increases the activity of the hypothalamic-pituitary-adrenal (HPA) axis, through the increase in CRF that in turn stimulates ACTH and β-endorphin secretion, while ACTH stimulates the adrenal corticosteroids secretion. If the surgical stress of ovariectomy can increase adrenal corticosteroids secretion and as the adrenals are responsible for progesterone secretion during the cycling rat, it is thus possible to assume that increased progesterone levels can be encountered under such circumstances. Flores et al 2005
also suggest that the response capacity to stress by the hypothalamuspituitary-adrenal axis can be manifested by increasing progesterone secretion.
Supplementation of the ovariectomized animals with daily subcutaneous 4µg/100 g BW estradiol benzoate resulted in a serum levels of estrogen and progesterone that is within the range of the diestrus./porestrus levels found in normal cycling rats though higher than the mean level achieved in our control group and also suggesting a positive effect of estrogen supplementation on the peripheral mechanisms controlling progesterone formation, a finding which was also reported in the study of Sunday et al.in 2006.
( 10) Supplementation of ovariectomized animals with a 4µg/100g BW daily estradiol benzoate therapy before induction of acute systemic inflammation resulted in a significant reduction in TNFα , C reative protein and ALT when compared to group III ovariectomized animals that received no hormonal supplementation before induction of systemic inflammation. Our results agree with Asai et al.
(33) who found that in the presence of LPS (at 1 ng/ml EC 50 of LPS), estradiol inhibited TNFα in both male and female subjects, but E2 had a stimulating effect in the absence of LPS.
According to Straub (34) , the effect of estrogen as pro-inflammatory or anti-inflammatory is greatly affected by several factors, namely, the type of stimulus whether it is a foreign or an auto-antigen and subsequent antigenspecific immune responses, for example estrogens seem to produce T cell inhibition and B cell activation. The effect of estrogen is also different depending on the target organ with its specific microenvironment; the timing of 17ß-estradiol administration in relation to the disease course and the reproductive status of a woman; the concentration of estrogens; the variability in expression of estrogen receptor alpha and ß in the organ studied; and the intracellular metabolism of estrogens leading to important biologically active metabolites with quite different antiand pro-inflammatory function.
Our results of the effect of estrogen on liver inflammation are supported by the findings of Xu et al. (35) who reported that E2 treatment for 8 weeks to proestrus levels reduced aspartate aminotransferase, alanine aminotransferase, hyaluronic acid, and type IV collagen in sera and lowered the synthesis of hepatic type I collagen significantly in both sexes , an effect which is blocked by tamoxifen.
Our results in group IV of animals supplemented by estrogen for three weeks after ovariectomy before induction of systemic inflammation showed a significant reduction of iNOS expression and Caspase III and COX II activity.
Weiner et al. (36) found that estrogen enhanced nitric oxide (NO) production , however this was the result of activation of the endothelial isoform of the enzyme NO synthase (NOS) and this activation seems to occur when no inflammatory mediator influence is involved.
In contrast, it has been documented that E2 at pregnancy levels inhibit LPS-induced TNF-α and NO production in primary rat microglia and mouse N9 microglial cells via iNOS inhibition (37) . Similar effects have been noticed in aortic endothelial cells and pleural cells in conditions of inflammation.
(38) . However, this inhibition seems to relate to the duration also of estrogen suppelementation before LPS are injected in the animals as short durations of one day extending to one week treatment after ovariectomy were associated with higher levels of iNOS and TNFα levels after the LPS challenge.
(39)
Our results of the effect of estrogen in the dose used on the expression of caspase 3 in the rat model have also been reported in human peripheral T lymphocytes by Takao et al. (40) where E2 at periovulatory to pregnancy levels for periods as short as 24 h reduced caspase 3 activity, which must be viewed as a strong and quick antiapoptotic effect.
However, Acconicia et al.
suggest that the E2-ER complex can activate both apoptotic and antiapoptic pathways according to the prevalence to either estrogen receptor apha (α) or beta ( ß) in the studied cell line. E2-ERα rapidly activates multiple signaling pathways (i.e., ERK/MAPK, phosphotidylinositol 3-kinase/Akt) committed to both cell cycle progression and prevention of apoptotic cascades. On the other hand, the E2-ERß complex induced the rapid and persistent phosphorylation of p38/MAPK, which in turn was involved in caspase 3 activation and cleavage of poly (ADP-ribose) polymerase, driving cells into the apoptotic cycle. E2 at 10 -8 M promotes cell survival through ER-α non-genomic signalling and cell death through ERß nongenomic signaling . Thus, the influence of E2 would be dependent on the abundance of either ERα or ERß.
In summary, our results seem to favour the view that estrogen in the dose used and for prolonged duration led to a generalised reduction in inflammatory markers especially the important mediators TNFα and iNOS and promoted an anti-apoptotic effect through inhibition of the action of Caspase 3 in liver tissue possibly promoting a generalised protective effect during states of acute systemic inflammation involving the liver tissue.
In contrast, our results suggest that progesterone in the dose used in group V (Ovx+SI+P) achieved a serum level as the levels usually encountered in the estrus part of the normal cycling female rat.
(42) . This level was associated with a generalised increase in inflammatory markers TNFα, C reactive protein, ALT in serum and , iNOS expression, COXII activity as well as Caspase 3 activity in liver tissue.
The addition of progesterone to estrogen partially counteracted the anti-inflammatory and anti-apoptotic effect of estrogen. Our results are similar to the results of Sunday et al However, in models of traumatic brain injury, exogenous progesterone (4 mg/kg) in male rats has been shown to reduce secondary neuronal loss and to attenuate brain edema (43) , independent of estrogen. The administration of progesterone (4 to 10 mg/kg) before or after the onset of transient focal cerebral ischemia in male rats or of global ischemia in ovariectomized cats greatly reduced ischemic cell damage and neurological deficits (44) . However, it is possible that the distribution of progesterone receptors in the male rat and in the cat is different from that observed in the female rat. Also, the effects of progesterone might be through other pathways that work independent of inflammation and apoptosis. It is also possible that the short duration of treatment could also influence the final effect of progesterone treatment suggesting that progesterone protective effects might be present at very closely monitored ranges of plasma with a potential for exacerbation of the inflammatory response if more prolonged durations of treatment are used.
In conclusion, we have found that the use of external estradiol benzoate in the doses and durations suggested in the ovariectomised female rats achieved levels similar to those found physiologically in proestrous and diestrous animals and resulted in a significant reduction of systemic and liver inflammatory and apoptotic markers in a model of acute systemic inflammation. Progesterone in the dose and duration used has achieved levels again as seen in the estrous phase of the rat cycle and resulted in exacerbation of inflammatory mediators and liver affection and tendency for apoptosis.
As the roles of estrogen an progesterone seem to be depending greatly on the dose used and the organ studied, more research is required to further eluciate the effects of such important hormones which might prove valuable tools in controlling the serious and frequently fatal effects of systemic endotoxemia and shock. Effect of time of exposure of serum to gel barrier tubes on results for progesterone and some
